[ 鐧诲綍] [ 鍏嶈垂娉ㄥ唽]
璇曞墏浠櫒缃? title=
浣嶇疆锛欬a href="/">棣栭〉> 浜у搧搴掽/a> > Pefloxacin Mesylate
绔嬪嵆鍜ㄨ
鍜ㄨ绫诲瀷锛欬/div>
*濮撳悕锛欬/div>
*鐢佃瘽锛欬/div>
*鍗曚綅锛欬/div>
Email锛欬/div>
*鐣欒█鍐呭锛欬/div>
璇疯缁嗚鏄庢偍鐨勯渶姹傘€
*楠岃瘉鐮侊細
Pefloxacin Mesylate
鏈骇鍝佷笉鍚戜釜浜洪攢鍞紝浠呯敤浣滅瀛︾爺绌讹紝涓嶇敤浜庝换浣曚汉浣撳疄楠屽強闈炵鐮旀€ц川鐨勫姩鐗╁疄楠屻€侟/div>
Pefloxacin Mesylate鍥剧墖
CAS NO: 70458-95-6
鍖呰涓庝环鏍硷細
鍖呰 浠锋牸(鍏?
10 mM * 1 mL in DMSO 鐢佃
100mg 鐢佃
500mg 鐢佃
1 g 鐢佃
5 g 鐢佃

浜у搧鍚嶇О
鐢茬:閰稿煿姘熸矙鏄烖br />Pefloxacinium mesylate
浜у搧浠嬬粛
Pefloxacin鏄姉鑿屽寲鍚堢墿锛岄€氳繃鎶戝埗DNA鏃嬭浆閰舵潵闃绘柇DNA澶嶅埗銆侟/div>
鐢熺墿娲绘€?/td>

Pefloxacin mesylate is a an antibacterial agent and preventsbacterialDNA replication by inhibiting DNA gyrase (topoisomerse) Target: DNA gyrase Pefloxacin is a synthetic chemotherapeutic agent used to treat severe and life-threateningbacterialinfections. Pefloxacin is commonly referred to as afluoroquinolone (or quinolone) drug and is a member of the fluoroquinolone class of antibacterials. It is an analog of norfloxacin. It is a synthetic fluoroquinolone, belonging to the 3rd generation of quinolones. Pefloxacin is extensively prescribed in France. Pefloxacin has not been approved for use in the United States. The bactericidal action of pefloxacin results from interference with the activity of thebacterialenzymes DNA gyrase andtopoisomeraseIV, which are needed for the transcription and replication ofbacterialDNA. DNA gyrase appears to be the primaryquinolonetarget for gram-negative bacteria.TopoisomeraseIV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of thebacterialchromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited.

IC50& Target

Quinolone

鍒嗗瓙閲廃/td>

429.46

鎬х姸

Solid

Formula

C18H24FN3O6S

CAS 鍙饵/td>

70458-95-6

涓枃鍚嶇О

鐢茬:閰稿煿姘熸矙鏄烖/p>

杩愯緭鏉′欢

Room temperature in continental US; may vary elsewhere.

鍌ㄥ瓨鏂瑰紡

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

婧惰В鎬ф暟鎹?/td>
In Vitro:

H2O : 鈮 100 mg/mL(232.85 mM)

DMSO : 12.5 mg/mL(29.11 mM;Need ultrasonic)

*"鈮? means soluble, but saturation unknown.

閰嶅埗鍌ㄥ娑秉/div>
娴撳害婧跺墏浣撶Н璐ㄩ噺 1 mg 5 mg 10 mg
1 mM 2.3285 mL 11.6425 mL 23.2851 mL
5 mM 0.4657 mL 2.3285 mL 4.6570 mL
10 mM 0.2329 mL 1.1643 mL 2.3285 mL
*

璇锋牴鎹骇鍝佸湪涓嶅悓婧跺墏涓殑婧惰В搴﹂€夋嫨鍚堥€傜殑婧跺墏閰嶅埗鍌ㄥ娑诧紱涓€鏃﹂厤鎴愭憾娑诧紝璇峰垎瑁呬繚瀛橈紝閬垮厤鍙嶅鍐昏瀺閫犳垚鐨勪骇鍝佸け鏁圏/b>銆侟/span>
鍌ㄥ娑茬殑淇濆瓨鏂瑰紡鍜屾湡闄愶細-80鈩? 6 months; -20鈩? 1 month (sealed storage, away from moisture)銆侟/span>-80鈩 鍌ㄥ瓨鏃讹紝璇峰湪 6 涓湀鍐呬娇鐢紝-20鈩 鍌ㄥ瓨鏃讹紝璇峰湪 1 涓湀鍐呬娇鐢ㄣ€侟/span>

In Vivo:

璇锋牴鎹偍鐨勫疄楠屽姩鐗╁拰缁欒嵂鏂瑰紡閫夋嫨閫傚綋鐨勬憾瑙f柟妗堛€備互涓嬫憾瑙f柟妗堥兘璇峰厛鎸夌収In Vitro鏂瑰紡閰嶅埗婢勬竻鐨勫偍澶囨恫锛屽啀渚濇娣诲姞鍔╂憾鍓傦細

鈥斺€斾负淇濊瘉瀹為獙缁撴灉鐨勫彲闈犳€э紝婢勬竻鐨勫偍澶囨恫鍙互鏍规嵁鍌ㄥ瓨鏉′欢锛岄€傚綋淇濆瓨锛涗綋鍐呭疄楠岀殑宸ヤ綔娑诧紝寤鸿鎮ㄧ幇鐢ㄧ幇閰嶏紝褰撳ぉ浣跨敤锛 浠ヤ笅婧跺墏鍓嶆樉绀虹殑鐧近br/>鍒嗘瘮鏄寚璇ユ憾鍓傚湪鎮ㄩ厤鍒剁粓婧舵恫涓殑浣撶Н鍗犳瘮锛涘鍦ㄩ厤鍒惰繃绋嬩腑鍑虹幇娌夋穩銆佹瀽鍑虹幇璞★紝鍙互閫氳繃鍔犵儹鍜?鎴栬秴澹扮殑鏂瑰紡鍔╂憾

  • 1.

    璇蜂緷搴忔坊鍔犳瘡绉嶆憾鍓傦細 PBS

    Solubility: 150 mg/mL (349.28 mM); Clear solution; Need ultrasonic

  • 2.

    璇蜂緷搴忔坊鍔犳瘡绉嶆憾鍓傦細 10% DMSO40%PEG3005%Tween-8045% saline

    Solubility: 鈮 1.25 mg/mL (2.91 mM); Clear solution

    姝ゆ柟妗堝彲鑾峰緱 鈮 1.25 mg/mL (2.91 mM锛岄ケ鍜屽害鏈煡) 鐨勬緞娓呮憾娑层€侟/p>

    浠 1 mL 宸ヤ綔娑蹭负渚嬶紝鍙 100 渭L 12.5 mg/mL 鐨勬緞娓 DMSO 鍌ㄥ娑插姞鍒 400 渭L PEG300 涓紝娣峰悎鍧囧寑锛涘悜涓婅堪浣撶郴涓姞鍏?0 渭L Tween-80锛屾贩鍚堝潎鍖€锛涚劧鍚庣户缁姞鍏 450 渭L鐢熺悊鐩愭按瀹氬鑷 1 mL銆侟/p>

    灏 0.9 g 姘寲閽狅紝瀹屽叏婧惰В浜 100 mL ddH2O 涓紝寰楀埌婢勬竻閫忔槑鐨勭敓鐞嗙洂姘存憾娑秉/div>
  • 3.

    璇蜂緷搴忔坊鍔犳瘡绉嶆憾鍓傦細 10% DMSO90% (20%SBE-尾-CDin saline)

    Solubility: 鈮 1.25 mg/mL (2.91 mM); Clear solution

    姝ゆ柟妗堝彲鑾峰緱 鈮 1.25 mg/mL (2.91 mM锛岄ケ鍜屽害鏈煡) 鐨勬緞娓呮憾娑层€侟/p>

    浠 1 mL 宸ヤ綔娑蹭负渚嬶紝鍙 100 渭L 12.5 mg/mL 鐨勬緞娓 DMSO 鍌ㄥ娑插姞鍒 900 渭L20% 鐨 SBE-尾-CD 鐢熺悊鐩愭按姘存憾娑秉/span>涓紝娣峰悎鍧囧寑銆侟/p>

    灏 2 g 纾轰竵鍩洪啔 尾-鐜硦绮惧姞鍏 5 mL 鐢熺悊鐩愭按涓紝鍐嶇敤鐢熺悊鐩愭按瀹氬鑷 10 mL锛屽畬鍏ㄦ憾瑙o紝婢勬竻閫忔槑
  • 4.

    璇蜂緷搴忔坊鍔犳瘡绉嶆憾鍓傦細 10% DMSO90%corn oil

    Solubility: 鈮 1.25 mg/mL (2.91 mM); Clear solution

    姝ゆ柟妗堝彲鑾峰緱 鈮 1.25 mg/mL (2.91 mM锛岄ケ鍜屽害鏈煡) 鐨勬緞娓呮憾娑诧紝姝ゆ柟妗堜笉閫傜敤浜庡疄楠屽懆鏈熷湪鍗婁釜鏈堜互涓婄殑瀹為獙銆侟/p>

    浠 1 mL 宸ヤ綔娑蹭负渚嬶紝鍙 100 渭L 12.5 mg/mL 鐨勬緞娓 DMSO 鍌ㄥ娑插姞鍒 900 渭L鐜夌背娌逛腑锛屾贩鍚堝潎鍖€銆侟/p>

*浠ヤ笂鎵€鏈夊姪婧跺墏閮藉彲鍦ㄦ湰缃戠珯閫夎喘銆侟/span>
Baidu
map